Children Are Protected by the COVID Vaccine
The Real Truth About Vaccines
Why do some people continue to think that children were not protected by the COVID vaccine?
The usual suspects…
Children Are Protected by the COVID Vaccine
In an interview with Dana Bash, Secretary RFK, Jr pushed the idea that COVID vaccines did more harm than good for children and that they did not protect children from COVID.
Of course, like everything else he said in the interview, RFK, Jr was wrong about COVID vaccines for kids.
And we can show him more than one study that shows COVID vaccines protected children!
Effectiveness of 2024–2025 COVID-19 Vaccines in Children in the United States — VISION, August 29, 2024–September 2, 2025 - found that vaccine effectiveness of 2024–2025 COVID-19 vaccination was an estimated 76% against COVID-19–associated emergency department or urgent care (ED/UC) visits among immunocompetent children aged 9 months–4 years and an estimated 56% among children and adolescents aged 5–17 years, compared with those who did not receive a 2024–2025 vaccine.
Effectiveness of BNT162b2 COVID-19 Vaccination in Children and Adolescents - BNT162b2 [Pfizer covid vaccine] protected children and adolescents against mild to moderate and severe COVID-19.
Effectiveness Associated With BNT162b2 Vaccine Against Emergency Department and Urgent Care Encounters for Delta and Omicron SARS-CoV-2 Infection Among Adolescents Aged 12 to 17 Years - These findings suggest that 2 doses of the BNT162b2 COVID-19 vaccine were associated with high levels of protection against ED and UC encounters related to the Delta and Omicron variants of SARS-CoV-2 in the first few months after vaccination.
OpenSAFELY: Effectiveness of COVID-19 Vaccination in Children and Adolescents - BNT162b2 vaccination in adolescents reduced COVID-19 A&E attendance and hospitalization
COVID-19 vaccine effectiveness and duration of protection among children and adolescents: A retrospective cohort study in 11 large cities in Japan - The protection against severe diseases was moderate, especially when the bivalent vaccine was used. The results reassure the importance of updated vaccination.
The effect of COVID-19 vaccine to the Omicron variant in children and adolescents: a systematic review and meta-analysis - During the Omicron variant epidemic, the vaccine provided protection against SARS-CoV-2 infection in children and adolescents aged 0-19 years. Two doses of vaccination can provide effective protection severe COVID-19, with booster vaccination additionally enhancing VE.
BNT162b2 COVID-19 vaccination uptake, safety, effectiveness, and waning in children and young people aged 5-11 years in Scotland - The BNT162b2 vaccine demonstrated a strong safety profile in this age group. Receiving both doses was linked to a reduction in the risk of symptomatic COVID-19 during the Omicron variant period, but this protection waned over the following six months.
Effectiveness of BNT162b2 COVID-19 primary series vaccination in children aged 5-17 years in the United States: a cohort study - Receipt of a complete BNT162b2 vaccine primary series was associated with overall reduced medically diagnosed COVID-19 and hospital/ED-diagnosed COVID-19 in children; observed VE estimates differed by age group and variant era.
COVID-19 vaccine effectiveness in the paediatric population aged 5-17 years: a multicentre cohort study using electronic health registries in six European countries, 2021 to 2022 - Vaccines recommended for 5-17-year-olds provided protection against COVID-19 hospitalisation, regardless of a previously documented infection of SARS-CoV-2, with high levels of protection in the first 3 months of the vaccination.
Effectiveness of the COVID-19 messenger RNA vaccine against symptomatic omicron infection in children aged 6 months to 11 years in Japan - In children aged 6 months to 4 years, as well as those aged 5-11 years, the COVID-19 mRNA vaccine was effective against symptomatic Omicron infection within 6 months after the last dose.
The impact of COVID-19 childhood and adolescent vaccination on mortality in Argentina - SARS-CoV-2 immunization was associated with reduced COVID-19 deaths for children and adolescents in Argentina.
COVID-19 Vaccination and Incidence of Pediatric SARS-CoV-2 Infection and Hospitalization - The findings of this case series analysis of 3 913 063 cases suggest reduced pediatric SARS-CoV-2 transmission following immunization. These results support the use of COVID-19 vaccines to reduce COVID-19 incidence and hospitalization in pediatric populations.
In fact, study after study has shown that COVID vaccines have protected children.
Also, tragically, we know that many kids died because they were sick with COVID.
And that most of the kids who died because they were sick with COVID were unvaccinated!
What else?
COVID vaccines are safe for children and teens!
Yes, there was a small risk of myocarditis with the original COVID vaccines, but the risks from COVID was far greater. And that small risk of myocarditis had disappeared with the latest, updated COVID vaccines!
More on Rewriting the History of COVID
Pandemic Revisionism Can’t Erase How Many Kids Died With COVID
Did Tom Shimabukuro Say COVID Vaccines Were Causing Debilitating Illnesses?
How Many People Have Died After Listening to Bad Advice About COVID?
Were Vaccinated Outnumbering the Unvaccinated During the Summer of 2021 COVID Surge?
Closing schools in the pandemic was bad. Keeping them all open would have been worse
Three years on, there is a new generation of lockdown sceptics – and they’re rewriting history
COVID-19 is a leading cause of death in children and young people in the US
Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025–2026
RFK is an unqualified, incompetent moron